Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

aprecias_zipdose_technology_in_action

Aprecia boosts 3D printing facilities at new US site

August 11, 2015 Manufacturing and Production, Research and Development

Aprecia Pharmaceuticals, which scored a world-first by becoming the first manufacturer to gain FDA approval for a three-dimensional printed (3DP) …
News
George Freeman

UK medical innovation backed with £18m Biomedical Catalyst fund

August 10, 2015 Research and Development, Sales and Marketing

Life Sciences Minister George Freeman has announced an £18 million fund for the next generation of UK medical advances. Twelve …
News
R&D

Sanofi, Evotec and Apeiron partner on immuno-oncology

August 10, 2015 Research and Development, Sales and Marketing Apeiron, Cancer, Evotec, Sanofi, immuno-oncology, immunotherapy, tumours

Sanofi is partnering with biotech companies Evotec and Apeiron to develop new cancer immuno-oncology therapies.The companies say the potential new …
News
MedImmune building Cambridge

MedImmune and Mirati to partner on lung cancer combo

August 6, 2015 Research and Development AstraZeneca, Cancer, MedImmune, Mirati, Mirati Therapeutics, NSCLC, durvalumab, immuno-oncology, immunotherapy, lung cancer, mocetinostat

MedImmune is entering into an exclusive clinical trial collaboration with US-based Mirati Therapeutics to test a novel immuno-oncology combination in …
News
astrazeneca image

AstraZeneca buys rights to Heptares experimental cancer treatment

August 6, 2015 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Cancer, HTL-1071, immuno-oncology

AstraZeneca has entered into a licensing agreement with Heptares for the global rights to the experimental cancer treatment HTL-1071. The …
News
Shire building

Shire goes public with rejected $30bn Baxalta bid

August 5, 2015 Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease

Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …
News

Lilly set for Cymbalta lawsuit showdown

August 5, 2015 Research and Development cymbalta, duloxetine, lawsuit, lilly

Lilly is contesting the first in a series of lawsuits brought by patients who say the company failed to inform …
News
Spritam

First 3D-printed drug approved by FDA

August 4, 2015 Manufacturing and Production, Research and Development 3d printing, FDA, manufacturing, production

The world of medicine saw a new pharma milestone this week, with the first approval by the FDA of a …
News
Teva image

Teva buys majority stake in genomic analysis firm

August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing CNS, Immuneering, Teva, central nervous system, genetic analysis

Teva has agreed to by a 51% equity share of genomic-analysis company Immuneering to advance treatments for diseases of the …
News
Shire building

Shire in $300m Foresight acquisition

August 4, 2015 Manufacturing and Production, Research and Development, Sales and Marketing FST-100, Foresight Biotherapeutics, Shire, conjunctivitis, dry eye, lifitegrast, pink eye

Shire has acquired Foresight Biotherapeutics for $300 million, as it looks to build its presence in eye diseases. The acquisition …
News
AZ sign

AstraZeneca and Isis Pharma in $65m drugs collaboration

August 3, 2015 Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D

Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …
News
WHO flag

Encouraging first results from trial of Merck’s Ebola vaccine

July 31, 2015 Research and Development, Sales and Marketing Africa, EBV, Ebola, Ebola virus, Ebola virus disease, Vaccine, WHO, World Health Organisation, guinea, vaccination

The first trial of an experimental Ebola vaccine suggests it provides high protection against the disease as early as ten …
News

BMS to trial Opdivo in solid tumours

July 30, 2015 Research and Development BMS, Bristol-Myers Squibb, Kyowa Hakko Kirin, Poteligeo, mogamulizumab, nivolumab, opdivo, solid tumours

Bristol-Myers Squibb will begin early-phase trials of its immuno-oncology treatment Opdivo with other cancer treatments, to see if the combination …
News
Takeda oncology

Takeda cancer drug gets EMA boost

July 29, 2015 Research and Development, Sales and Marketing Takeda, ixazomib, multiple myeloma

The EMA has granted Takeda an accelerated assessment for its multiple myeloma drug, ixazomib. The Agency’s Committee for Medicinal Products …
News

David Khougazian announced as president of Sanofi Pasteur MSD

July 29, 2015 Business Services, Research and Development, Sales and Marketing MSD, Merck, Sanofi Pasteur

Sanofi Pasteur and Merck have appointed David Khougazian as president of their joint company, Sanofi Pasteur MSD. David Khougazian joined …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026